| Dr Jason M Stinnett, MD | |
|
1492 W Antelope Dr, Suite 125, Layton, UT 84041-1139 | |
| (801) 525-3022 | |
| (801) 775-9508 |
| Full Name | Dr Jason M Stinnett |
|---|---|
| Gender | Male |
| Speciality | Medical Oncology |
| Experience | 26 Years |
| Location | 1492 W Antelope Dr, Layton, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861501694 | NPI | - | NPPES |
| P00388855 | Other | UT | RAILROAD MEDICARE |
| 107055831101 | Other | UT | SELECT HEALTH |
| QMP000003378087 | Other | UT | MOLINA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | M9050 (Idaho) | Secondary |
| 207RX0202X | Internal Medicine - Medical Oncology | 379443-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Davis Hospital And Medical Center | Layton, UT | Hospital |
| Layton Hospital | Layton, UT | Hospital |
| Mckay Dee Hospital | Ogden, UT | Hospital |
| Ogden Regional Medical Center | Ogden, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Utah Cancer Specialists Pc | 1355254749 | 39 |
News Archive
Childhood immunizations keep our children safe from a number of serious diseases. This is a good time of year to make sure your child is up-to-date on all of his/her immunizations. Continue reading to find out which vaccines the Centers for Disease Control and Prevention (CDC) recommend for children 6 and under.
Thirty percent of patients surveyed experienced an infection as a result of chemotherapy, 45 percent of which were associated with neutropenia or febrile neutropenia according to findings from a pan-European patient and nurse survey presented today at the 7th Annual European Oncology Nursing Society Spring Convention.
Helsinn Group, the company focused on building quality cancer care, today announces that rights to anamorelin, its innovative ghrelin receptor agonist, have been granted in Turkey to GEN Ilaç.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that its drug candidate bafetinib (formerly known as INNO-406) demonstrated statistically significant inhibition of glioblastoma multiforme cell lines in a preclinical trial. Glioblastoma multiforme is the most common and aggressive primary adult brain tumor.
› Verified 5 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079 |
News Archive
Childhood immunizations keep our children safe from a number of serious diseases. This is a good time of year to make sure your child is up-to-date on all of his/her immunizations. Continue reading to find out which vaccines the Centers for Disease Control and Prevention (CDC) recommend for children 6 and under.
Thirty percent of patients surveyed experienced an infection as a result of chemotherapy, 45 percent of which were associated with neutropenia or febrile neutropenia according to findings from a pan-European patient and nurse survey presented today at the 7th Annual European Oncology Nursing Society Spring Convention.
Helsinn Group, the company focused on building quality cancer care, today announces that rights to anamorelin, its innovative ghrelin receptor agonist, have been granted in Turkey to GEN Ilaç.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that its drug candidate bafetinib (formerly known as INNO-406) demonstrated statistically significant inhibition of glioblastoma multiforme cell lines in a preclinical trial. Glioblastoma multiforme is the most common and aggressive primary adult brain tumor.
› Verified 5 days ago
| Entity Name | Utah Cancer Specialists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619925369 PECOS PAC ID: 1355254749 Enrollment ID: O20031111000618 |
News Archive
Childhood immunizations keep our children safe from a number of serious diseases. This is a good time of year to make sure your child is up-to-date on all of his/her immunizations. Continue reading to find out which vaccines the Centers for Disease Control and Prevention (CDC) recommend for children 6 and under.
Thirty percent of patients surveyed experienced an infection as a result of chemotherapy, 45 percent of which were associated with neutropenia or febrile neutropenia according to findings from a pan-European patient and nurse survey presented today at the 7th Annual European Oncology Nursing Society Spring Convention.
Helsinn Group, the company focused on building quality cancer care, today announces that rights to anamorelin, its innovative ghrelin receptor agonist, have been granted in Turkey to GEN Ilaç.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that its drug candidate bafetinib (formerly known as INNO-406) demonstrated statistically significant inhibition of glioblastoma multiforme cell lines in a preclinical trial. Glioblastoma multiforme is the most common and aggressive primary adult brain tumor.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jason M Stinnett, MD 1121 E 3900 S, Suite C-240, Salt Lake City, UT 84124-1214 Ph: (801) 262-9494 | Dr Jason M Stinnett, MD 1492 W Antelope Dr, Suite 125, Layton, UT 84041-1139 Ph: (801) 525-3022 |
News Archive
Childhood immunizations keep our children safe from a number of serious diseases. This is a good time of year to make sure your child is up-to-date on all of his/her immunizations. Continue reading to find out which vaccines the Centers for Disease Control and Prevention (CDC) recommend for children 6 and under.
Thirty percent of patients surveyed experienced an infection as a result of chemotherapy, 45 percent of which were associated with neutropenia or febrile neutropenia according to findings from a pan-European patient and nurse survey presented today at the 7th Annual European Oncology Nursing Society Spring Convention.
Helsinn Group, the company focused on building quality cancer care, today announces that rights to anamorelin, its innovative ghrelin receptor agonist, have been granted in Turkey to GEN Ilaç.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that its drug candidate bafetinib (formerly known as INNO-406) demonstrated statistically significant inhibition of glioblastoma multiforme cell lines in a preclinical trial. Glioblastoma multiforme is the most common and aggressive primary adult brain tumor.
› Verified 5 days ago
Khaldoun M Al-rayess, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2121 N 1700 W, Layton, UT 84041 Phone: 801-773-4840 Fax: 801-525-8151 | |
Abdulelah Y Abu Qare, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 W Antelope Dr, Layton, UT 84041 Phone: 801-773-4840 Fax: 801-525-8151 | |
Mr. Brady John Tucker, PA-C Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2121 N 1700 W, Layton, UT 84041 Phone: 801-773-4840 Fax: 801-525-8151 | |
Dr. Ryan P Mcdonald, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2132 N 1700 W, Suite 110, Layton, UT 84041 Phone: 801-779-3500 Fax: 801-779-3508 | |
Gary J Alexander, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2121 N 1700 W, Layton, UT 84041 Phone: 801-773-4840 Fax: 801-525-8151 | |
R Robert Taylor, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2121 No 1700 W, Layton, UT 84041 Phone: 801-773-4840 Fax: 801-525-8187 | |
Mr. Brett Michael Rawlins, FNP Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 W Layton Pkwy Ste 4c, Layton, UT 84041 Phone: 801-475-3280 |